In this episode of Pharmacy Inside Jobs, senior features editor Dawn Connelly talks to Gurmat Khangura, a specialist in neurodevelopmental conditions.
Khangura has more than 15 years of experience as a mental health pharmacist and is currently working within the neurodevelopmental pathway of a Child and Adolescent Mental Health Service, covering Shropshire, Telford and Wrekin.
He is an independent prescriber and is responsible for conducting ADHD assessments for young people and providing evidence-based interventions to support them and their families following a diagnosis. Khangura has also founded his own private practice, where he provides ADHD and autism assessments for children and adults.
This episode was produced by Geoff Marsh, with editorial support from executive editor Carolyn Wickware.
Pharmacy Inside Jobs
Our new PJ Pod series — Pharmacy Inside Jobs — has been developed to inspire you to take the next step in your career. Whether you are a pharmacy student or a seasoned pharmacy professional, our goal is to provide insights into the increasingly diverse roles that exist within the profession.
In each episode, we will be joined by a guest to explore their career journey so far, with a focus on their current role and the opportunities, challenges and rewards that it brings. We will also find out which skills are needed to succeed in their role and how you could follow in their footsteps.
In case you missed it, our first Pharmacy Inside Jobs episode featured prison pharmacist Kaniksha Aggarwal, who lifts the lid on what it is like to work as an advanced pharmacist specialist in a men’s prison. You can listen to that episode here.
2 comments
You must be logged in to post a comment.
Very insightful listening to this episode on ADHD assessment. And i'd like to say the same for the previous episode listening to Kaniksha about prison pharmacy. Well done PJ team. Keep up the good work!
Very interesting. Amazing how ADHD diagnosis has increased over the years.
In the US it’s been the same trend but non stimulant ( amphetamine) based meds are increasing .
Neurotransmitter non stimulants agents are increasing thankfully